Journal Information
Vol. 97. Issue 3.
Pages 273-279 (May - June 2021)
Share
Share
Download PDF
More article options
Visits
3052
Vol. 97. Issue 3.
Pages 273-279 (May - June 2021)
Review article
Open Access
Vitamin D deficiency in children and adolescents with obesity: a meta-analysis
Visits
3052
Verônica Indicatti Fiamenghi
Corresponding author
vfiamenghi@hcpa.edu.br

Corresponding author.
, Elza Daniel de Mello
Universidade Federal do Rio Grande do Sul (UFRGS), Programa de Pós-Graduação em Saúde da Criança e do Adolescente, Porto Alegre, RS, Brazil
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (1)
Table 1. Characteristics of the studies included in the final analysis.
Additional material (1)
Abstract
Objective

To evaluate the prevalence of vitamin D deficiency in obese children and adolescents when compared to eutrophic controls.

Methods

Systematic review with meta-analysis covering studies with patients aged 0–18 years old diagnosed with obesity and vitamin D deficiency and control group of eutrophic patients. The studies were retrieved in the PubMed, Embase, and LILACS databases in December 2019. The search used the terms “obesity” in combination with “pediatric population” and “vitamin D”.

Results

Through the search 3155 articles were retrieved; and after analysis, 20 studies were selected according to the study objectives. A total of 24,600 children and adolescents were included. Through meta-analysis, the relative risk for the association between obesity and vitamin D deficiency in the pediatric population was 1.41 (95% CI: 1.26–1.59) (I² = 89%, p < 0.01).

Conclusion

Children and adolescents with obesity have higher risk of vitamin D deficiency.

Keywords:
Obesity
Vitamin D
Meta-analysis
Children
Adolescent
Full Text
Introduction

Childhood obesity is a worldwide problem.1 It is known that overweight in childhood and adolescence is an important risk factor for obesity in adulthood, as well as for the development of comorbidities.1

Regarding vitamin D (vit D), in addition to its role in bone health and calcium and phosphorus metabolism, its role in immune functions and in decreasing the risk of chronic illnesses has been considered.2,3 Vit D deficiency varies by geographic region, with an estimated prevalence of 15% in a study with the general pediatric population in the United States of America from 1 to 11 years of age.4 A similar prevalence of 14% was found in a cross-sectional survey in a representative sample of adolescents from that country aged 12–19.5 The best indicator to assess vit D status is the metabolite 25-hydroxy vitamin D (25[OH]D).6

The relationship between hypovitaminosis D and obesity has been widely studied in the general population. A meta-analysis published in 2015 showed an association between vit D deficiency and obesity, with OR 3.43 (95% CI: 2.33–5.06).7

Vit D deficiency and excess body fat have mutual negative effects, resulting from metabolic processes that generate accumulation of inactive forms and decreased vit D bioavailability, in addition to decreased tissue secretion and sensitivity to insulin.8 There is no consensus as to why vit D levels are lower in obese individuals. The main hypothesis would be the absorption of vit D, which is fat soluble, by the adipose tissue.9

Thus, it is known that obesity is related with hypovitaminosis D, with consequent greater chance of changes in glycemic control and metabolic syndrome in general population.10,11 Although this relationship is clear in the adult population, there is no consensus on the literature regarding a higher frequency of vit D deficiency in children and adolescents with obesity.

Methods

The literature search, study selection based on title and abstract, and data extraction were carried out independently by two trained reviewers. In cases of disagreement, it was resolved by the reviewers. In case of duplicate articles, only one was considered. The meta-analysis is registered on the PROSPERO Platform (PROSPERO, University of York, England) under number CRD42019137788.

Search strategy

The studies were identified through research in the PubMed, Embase, and LILACS databases, performed in December 2019. For the search, the term “obesity” was used in combination with “pediatric population” and “vitamin D”, through structured Medical Subject Heading (MeSH) keywords for PubMed, Emtree for Embase, and Health Science Descriptors (DeCS) for LILACS. The terms used in the search and the number of articles retrieved per database are depicted in Table S1 of the Supplementary material.

Eligibility criteria

The inclusion criteria were as follows: studies published in Portuguese, English, Spanish, or French, published on any date, evaluating patients aged 0–18 years old with diagnosis of obesity and vit D deficiency, with control group of eutrophic patients. Data related to patients with comorbidities that alter vit D metabolism (e.g. kidney, liver, gastrointestinal, or endocrine disease) or using medications that act in the metabolism of this vitamin (e.g., glucocorticoids), and studies with incomplete or data not published in full were excluded.

Data collection

After assessing the title, abstract, and full text of the studies according to the eligibility criteria, the data of interest were collected using a standard form. The following information was collected: authors, study place, design, year of publication, age of participants, 25(OH)D levels characterized as deficiency, method for assessing 25(OH)D levels, obesity definition by body mass index (BMI), number of patients with obesity and the respective number of patients with vit D deficiency, and number of eutrophic patients and the respective number of patients with vit D deficiency in this group.

Statistical analysis

The studies were grouped in a meta-analysis. The summary measure used was relative risk (RR) with 95% confidence interval, weighted by the study power, using the random effect model. The inconsistency test (I²) was used to assess heterogeneity between studies. A p-value <0.05 was considered to be statistically significant. The statistical analysis was performed using the “meta” package of the R program (R Core Team [2017]. R: A language and environment for statistical computing. R Foundation for Statistical Computing, v. 3.5.1 — Vienna, Austria).

Results

During the search 3155 articles were retrieved, of which 20 studies were relevant to the objectives of this study (Table 112–31). The flowchart showing the search results and selection details is depicted in Fig. 1. A total of 24,600 children were included.

Table 1.

Characteristics of the studies included in the final analysis.

Study  Country  Study type  Age (years)  25(OH)D cutoff point (ng/mL)  Method for evaluation of 25(OH)D  Definition of obesity by BMI  Obese (n)  Vit D deficiency in obese (%)  Control (n)  Vit D deficiency in control (%) 
Rajakumar et al.20  United States  Cross-sectional  6–10  <20  Immunoassay  >p95  21  57  20  40 
Elizondo-Montemayor et al.21  Mexico  Cross-sectional  6–12  <20  Immunoassay  ≥p95  99  27  99  13 
Khor et al.22  Malaysia  Cross-sectional  7–12  <20  Immunoassay  ≥p95  66  90  336  84 
Rajakumar et al.23  United States  Cross-sectional  8–18  <20  Immunoassay  ≥p95  112  65  125  47 
Sacheck et al.24  United States  Cross-sectional  9–14  <20  Immunoassay  ≥p95  65  80  198  71 
Absoud et al.25  England  Cross-sectional  4–18  <20  Immunoassay  ≥p95  247  39  852  34 
Olson et al.26  United States  Cross-sectional  6–16  <20  Immunoassay  ≥p95  411  50  87  21 
Turer et al.27  United States  Cross-sectional  6–18  <20  Immunoassay  ≥p95  2478  37  9814  22 
Bellone et al. 28  Italy  Cross-sectional  Pediatric patients  <20  Immunoassay  >p95  444  44  113  31 
Dyląg et al.18  Poland  Cross-sectional  1–5  <20  Immunoassay  ≥p97  50  42  50  22 
Zhang et al.12  China  Cross-sectional  7–11  <20  Chromatography  ≥p95  164  69  1324  55 
Huang et al.14  China  Cross-sectional  6–16  <12  Immunoassay  ≥p95  348  18  445 
Jari et al.15  Iran  Cross-sectional  10–18  <10  Immunoassay  ≥p95  104  41  986  40 
Al-Sadat et al.16  Malaysia  Cross-sectional  12–13  <15  Immunoassay  ≥p95  116  88  1234  78 
Wang et al.17  China  Cross-sectional  8–18  <12  –  ≥p95  103  175 
Wakayo et al.13  Ethiopia  Cross-sectional  11–18  <20  Chromatography  Unavailable  18  77  156  39 
Moore et al.29  United States  Cross-sectional  6–18  <20  –  ≥p95  582  56  1900  40 
Barja-Fernandez et al.30  Spain  Cross-sectional  2–18  <20  Immunoassay  ≥p95  176  79  295  108 
Durá-Travé et al.19  Spain  Cross-sectional  3.1–15.4  <20  Immunoassay  >p97  119  32  459  57 
Shulhai et al.31  Ukraine  Cross-sectional  12–17  <20  Immunoassay  >p95  78  60  131  84 

BMI, body mass index.

Figure 1.

Flowchart with the search results and selection details.

(0.25MB).

The studies were all carried out in countries located in the Northern Hemisphere. None of the studies performed in tropical countries fulfilled the inclusion criteria. The United States is the country with the most publications (n = 6), followed by three studies carried out in China.

Zhang et al.12 and Wakayo et al.13 evaluated 25(OH)D levels using chromatography, all others studies used immunoassay techniques. Regarding the cutoff point used to define 25(OH)D deficiency, the value of 20 ng/mL was the most frequently used, with only four studies using other cutoff points — Huang et al.,14 Jari et al.,15 Al-sadat et al.,16 and Wang et al.17 There were also different definitions of obesity among the studies. Although most of them have used the definition of BMI equal or higher 95th percentile for age, Dyląg et al.18 and Durá-Travé et al.19 used the 97th percentile for age the as cutoff point.

In meta-analysis, the relative risk for the association between vit D deficiency and obesity was 1.41 (95% CI = 1.26–1.59), (I² = 89%, p < 0,01), as shown in the forest plot (Fig. 2).

Figure 2.

Forest plot of the total study sample and the association between vit D deficiency and obesity.

(0.47MB).

Heterogeneity was found among the studies, although the random effect model was used for meta-analysis. The study that contributed the most for heterogeneity was Turer et al.27 A sensitivity analysis was performed by excluding this study from the present analysis, and the relative risk did not change drastically.

Some studies reported other factors associated with vit D deficiency. Khor et al.22 demonstrated higher prevalence of vit D deficiency in girls (77.5%) than boys (66.1%), with statistical significance (p = 0.01). Rajakumar et al.23 and Turer et al.27 evidenced lower prevalence of hypovitaminosis D in individuals with white skin color, and in the summer and autumn seasons. The study by Shulhai et al.31 with Ukrainian children and adolescents reported a significant effect in the development of vit D deficiency in individuals who spend more than four hours a day in front of computer or television (p = 0.027).

Two studies also evaluated insulin resistance and its relationship with hypovitaminosis D. Wang et al.17 used fasting glucose and serum insulin measurements to estimate insulin resistance through homeostatic model assessment (HOMA-IR) in 278 children and adolescents. In multiple linear regression, there was association among HOMA-IR, BMI, and vit D deficiency (p < 0.001). Huang et al.14 also reported negative association between serum vit D and HOMA-IR in obese children and adolescents.

The severity of obesity also seems to be related with 25(OH)D levels. Turer et al.27 demonstrated that half of the children with severe obesity presented with hypovitaminosis D and even after statistical adjustment for confounding variables, these children have more than double the risk to present with vit D deficiency compared to eutrophic controls.

A funnel plot analysis showed the presence of publication bias (Fig. 3).

Figure 3.

Funnel plot of the studies included in meta-analysis.

(0.06MB).
Discussion

This meta-analysis summarized the data from 20 cross-sectional studies that assessed vit D deficiency in obese and also in eutrophic children and adolescents, comprising a total of 24,600 patients.

The hypothesis that children and adolescents with excess weight present higher prevalence of vit D deficiency when compared to control group of eutrophic patients was confirmed. The most accepted physiopathologic basis is that vit D, being fat-soluble, is over-absorbed by adipose tissue.9 The data that excessive screen time (television, computers, and tablets) is also related to lower vit D levels reinforces the idea that the association between childhood obesity and hypovitaminosis D appears to be multifactorial, also influenced by diminished exposure to outdoor activities and sunlight.27,31

It should be noted that all studies included in the review were carried out in the Northern Hemisphere. Although in Brazil the majority of the population resides in regions with adequate sun exposure, hypovitaminosis D is also a common problem. A study with 135 healthy Brazilian adolescents showed a prevalence of vit D deficiency of 60%.32 In another Brazilian study performed with healthy infants aged between six and 24 months, 6% presented deficient serum vit D concentration, which suggests that vit D deficiency may also vary with age.33 The Brazilian Society of Pediatrics recommends the prevention of deficiency through the supplementation of vit D in children on exclusive breastfeeding, children using fortified milk formula that ingest volumes less than 1000 mL/day, children and adolescents who do not ingest at least 600 IU/day of vit D in the diet or that are not exposed to the sun regularly, regardless of the region of the country.34

Epidemiological data on the prevalence of childhood obesity and hypovitaminosis D in pediatrics are worrying. Knowing the immunological functions of vit D and its influence on insulin resistance mechanisms, it is necessary to discuss therapeutic measures that can minimize the consequences on the current and future health of children and adolescents with excess weight and disability from vit D deficiency.35

Studies show that the obese pediatric population does not show the same response to vit D supplementation in the doses routinely used when compared with eutrophic controls.36,37 There is no consensus on the universally recommended dose for the treatment of hypovitaminosis D in this population; however, authors suggest an increase in the dose used regularly.36,38

It is also essential to reinforce the importance of lifestyle changes in the pediatric population. It is necessary to encourage the practice of physical exercise, the reduction of screen time, and the adoption of healthy eating habits in order to reduce the prevalence of overweight and obesity in children and adolescents and the impact of associated comorbidities, including vit D deficiency.39

Limitations

Some limitations of this meta-analysis must be recognized. The systematic review was limited to the published literature and the publication bias should be considered. There was high heterogeneity between the studies evaluated, which was minimized by the use of the random effect model. The studies used different cutoff points for 25(OH)D deficiency, a factor involved in heterogeneity. Also, hypovitaminosis D has a known multifactorial etiology, which is a possible confounding factor in the analysis. As it is a meta-analysis of cross-sectional studies, it is not possible to infer a cause-effect relationship between the variables studied. Despite the language limitation in inclusion criteria for the convenience of the researchers, the impact was minimal, since only two studies were excluded due to this criterion.

Conclusion

This meta-analysis demonstrated an association between obesity and vit D deficiency in the pediatric population. This finding reinforces the importance of stimulating healthy lifestyle habits and highlights the need to assess levels of 25(OH)D in obese children and adolescents.

Conflicts of interest

The authors declare no conflicts of interest.

Appendix A
Supplementary data

The following is Supplementary data to this article:

References
[1]
NCD Risk Factor Collaboration (NCD-RisC).
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults.
Lancet, 390 (2017), pp. 2627-2642
[2]
W. Dankers, E.M. Colin, J.P. van Hamburg, E. Lubberts.
Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential.
Front Immunol, 7 (2017), pp. 697
[3]
M.F. Holick.
Vitamin D deficiency.
N Engl J Med, (2007), pp. 115-127
[4]
J.M. Mansbach, A.A. Ginde, C.A. Camargo Jr.
Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D?.
Pediatrics, 124 (2009), pp. 1404-1410
[5]
S. Saintonge, H. Bang, L.M. Gerber.
Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III.
Pediatrics, 123 (2009), pp. 797-803
[6]
S.S. Maeda, V.Z. Borba, M.B. Camargo, D.M. Silva, J.L. Borges, F. Bandeira, et al.
Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D.
Arq Bras Endocrinol Metabol, 58 (2014), pp. 411-433
[7]
Y. Yao, L. Zhu, L. He, Y. Duan, W. Liang, Z. Nie, et al.
A meta-analysis of the relationship between vitamin D deficiency and obesity.
Int J Clin Exp Med, 8 (2015), pp. 14977-14984
[8]
I. Zakharova, L. Klimov, V. Kuryaninova, I. Nikitina, S. Malyavskaya, S. Dolbnya, et al.
Vitamin D insufficiency in overweight and obese children and adolescents.
Front Endocrinol (Lausanne), 10 (2019), pp. 103
[9]
J. Wortsman, L.Y. Matsuoka, T.C. Chen, Z. Lu, M.F. Holick.
Decreased bioavailability of vitamin D in obesity.
Am J Clin Nutr, 72 (2000), pp. 690-693
[10]
D.D. Bikle.
Vitamin D metabolism, mechanism of action, and clinical applications.
Chem Biol, 21 (2014), pp. 319-329
[11]
K.S. Vimaleswaran, A. Cavadino, D.J. Berry, Genetic Investigation of Anthropometric Traits (GIANT) Consortium, J.C. Whittaker, C. Power, et al.
Genetic association analysis of vitamin D pathway with obesity traits.
Int J Obes (Lond), 37 (2013), pp. 1399-1406
[12]
H.Q. Zhang, J.H. Teng, Y. Li, X.X. Li, Y.H. He, X. He, et al.
Vitamin D status and its association with adiposity and oxidative stress in schoolchildren.
Nutrition, 30 (2014), pp. 1040-1044
[13]
T. Wakayo, S.J. Whiting, T. Belachew.
Vitamin D deficiency is associated with overweight and/or obesity among schoolchildren in Central Ethiopia: a cross-sectional study.
Nutrients, 8 (2016), pp. 190
[14]
K. Huang, Y.J. Jiang, J.F. Fu, J.F. Liang, H. Zhu, Z.W. Zhu, et al.
The relationship between serum 25-hydroxyvitamin D and glucose homeostasis in obese children and adolescents in Zhejiang, China.
Endocr Pract, 21 (2015), pp. 1117-1124
[15]
M. Jari, M. Qorbani, M. Moafi, M.E. Motlagh, M. Keikha, G. Ardalan, et al.
Association of 25-hydroxy vitamin D levels with indexes of general and abdominal obesity in Iranian adolescents: the CASPIAN-III study.
J Res Med Sci, 20 (2015), pp. 122-126
[16]
N. Al-Sadat, H.A. Majid, P.Y. Sim, T.T. Su, M. Dahlui, M.F. Abu Bakar, et al.
Vitamin D deficiency in Malaysian adolescents aged 13 years: findings from the Malaysian Health and Adolescents Longitudinal Research Team study (MyHeARTs).
[17]
L. Wang, H. Wang, H. Wen, H. Tao, X. Zhao.
Relationship between HOMA-IR and serum vitamin D in Chinese children and adolescents.
J Pediatr Endocrinol Metab, 29 (2016), pp. 777-781
[18]
H. Dyląg, G. Rowicka, M. Strucińska, A. Riahi.
Assessment of vitamin D status in children aged 1–5 with simple obesity.
Rocz Panstw Zakl Hig, 65 (2014), pp. 325-330
[19]
T. Durá-Travé, F. Gallinas-Victoriano, M.J. Chueca-Guindulain, S. Berrade-Zubiri, P. Moreno-Gónzalez, M. Malumbres-Chacón.
Prevalence of hypovitaminosis D and associated factors in Spanish population of school children and adolescents.
Aten Primaria, 50 (2018), pp. 422-429
[20]
K. Rajakumar, J.D. Fernstrom, M.F. Holick, J.E. Janosky, S.L. Greenspan.
Vitamin D status and response to Vitamin D(3) in obese vs. non-obese African American children.
Obesity (Silver Spring), 16 (2008), pp. 90-95
[21]
L. Elizondo-Montemayor, P.A. Ugalde-Casas, M. Serrano-González, C.A. Cuello-García, J.R. Borbolla-Escoboza.
Serum 25-hydroxyvitamin d concentration, life factors and obesity in Mexican children.
Obesity (Silver Spring), 18 (2010), pp. 1805-1811
[22]
G.L. Khor, W.S. Chee, Z.M. Shariff, B.K. Poh, M. Arumugam, J.A. Rahman, et al.
High prevalence of vitamin D insufficiency and its association with BMI-for-age among primary school children in Kuala Lumpur, Malaysia.
BMC Public Health, 11 (2011), pp. 95
[23]
K. Rajakumar, J. de las Heras, T.C. Chen, S. Lee, M.F. Holick, S.A. Arslanian.
Vitamin D status, adiposity, and lipids in Black American and Caucasian children.
J Clin Endocrinol Metab, 96 (2011), pp. 1560-1567
[24]
J. Sacheck, E. Goodman, K. Chui, V. Chomitz, A. Must, C. Economos.
Vitamin D deficiency, adiposity, and cardiometabolic risk in urban schoolchildren.
J Pediatr, 159 (2011), pp. 945-950
[25]
M. Absoud, C. Cummins, M.J. Lim, E. Wassmer, N. Shaw.
Prevalence and predictors of vitamin D insufficiency in children: a Great Britain population based study.
[26]
M.L. Olson, N.M. Maalouf, J.D. Oden, P.C. White, M.R. Hutchison.
Vitamin D deficiency in obese children and its relationship to glucose homeostasis.
J Clin Endocrinol Metab, 97 (2012), pp. 279-285
[27]
C.B. Turer, H. Lin, G. Flores.
Prevalence of vitamin D deficiency among overweight and obese US children.
Pediatrics, 131 (2013), pp. e152-61
[28]
S. Bellone, S. Esposito, E. Giglione, G. Genoni, C. Fiorito, A. Petri, et al.
Vitamin D levels in a paediatric population of normal weight and obese subjects.
J Endocrinol Invest, 37 (2014), pp. 805-809
[29]
C.E. Moore, Y. Liu.
Low serum 25-hydroxyvitamin D concentrations are associated with total adiposity of children in the United States: National Health and Examination Survey 2005 to 2006.
Nutr Res, 36 (2016), pp. 72-79
[30]
S. Barja-Fernández, C.M. Aguilera, I. Martínez-Silva, R. Vazquez, M. Gil-Campos, J. Olza, et al.
25-Hydroxyvitamin D levels of children are inversely related to adiposity assessed by body mass index.
J Physiol Biochem, 74 (2018), pp. 111-118
[31]
A.M. Shulhai, H. Pavlyshyn, O. Shulhai.
Peculiarities of the prevalence and risk factors for vitamin D deficiency in overweight and obese adolescents in Ukraine.
Arch Balk Med Union, 54 (2019), pp. 57-63
[32]
B.S. Peters, L.C. dos Santos, M. Fisberg, R.J. Wood, L.A. Martini.
Prevalence of vitamin D insufficiency in Brazilian adolescents.
Ann Nutr Metab, 54 (2009), pp. 15-21
[33]
A.C. Almeida, F.J. de Paula, J.P. Monteiro, A.C. Nogueira-de-Almeida, L.A. Del Ciampo, D.C. Aragon, et al.
Do all infants need vitamin D supplementation?.
[34]
Sociedade Brasileira de Pedriatria (SBP), Departamento Científico de Endocrinologia.
Hipovitaminose D em pediatria: recomendações para o diagnóstico, tratamento e prevenção.
Guia Prático de Atualização, (2016), pp. 1-11
[35]
I. Zakharova, L. Klimov, V. Kuryaninova, I. Nikitina, S. Malyavskaya, S. Dolbnya, et al.
Vitamin D insufficiency in overweight and obese children and adolescents.
Front Endocrinol (Lausanne), 10 (2019), pp. 103
[36]
R. Aguirre Castaneda, N. Nader, A. Weaver, R. Singh, S. Kumar.
Response to vitamin D3 supplementation in obese and non-obese Caucasian adolescents.
Horm Res Paediatr, 78 (2012), pp. 226-231
[37]
Z. Harel, P. Flanagan, M. Forcier, D. Harel.
Low vitamin D status among obese adolescents: prevalence and response to treatment.
J Adolesc Health, 48 (2011), pp. 448-452
[38]
M. Vidailhet, E. Mallet, A. Bocquet, J.L. Bresson, A. Briend, J.P. Chouraqui, et al.
Vitamin D: still a topical matter in children and adolescents. A position paper by the Committee on Nutrition of the French Society of Paediatrics.
Arch Pediatr, 19 (2012), pp. 316-328
[39]
S. Kumar, A.S. Kelly.
Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment.
Mayo Clin Proc, 92 (2017), pp. 251-265
Copyright © 2020. Sociedade Brasileira de Pediatria
Idiomas
Jornal de Pediatria (English Edition)
Article options
Tools
Supplemental materials
en pt
Taxa de publicaçao Publication fee
Os artigos submetidos a partir de 1º de setembro de 2018, que forem aceitos para publicação no Jornal de Pediatria, estarão sujeitos a uma taxa para que tenham sua publicação garantida. O artigo aceito somente será publicado após a comprovação do pagamento da taxa de publicação. Ao submeterem o manuscrito a este jornal, os autores concordam com esses termos. A submissão dos manuscritos continua gratuita. Para mais informações, contate assessoria@jped.com.br. Articles submitted as of September 1, 2018, which are accepted for publication in the Jornal de Pediatria, will be subject to a fee to have their publication guaranteed. The accepted article will only be published after proof of the publication fee payment. By submitting the manuscript to this journal, the authors agree to these terms. Manuscript submission remains free of charge. For more information, contact assessoria@jped.com.br.
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.